Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 57,192 | 50,303 | 45,095 | 54,515 | 41,494 |
| Cost of Goods | 8,909 | 7,752 | 5,395 | 6,769 | 1,563 |
| Gross Profit | 48,283 | 42,551 | 39,700 | 47,746 | 39,931 |
| Operating Expenses | 48,724 | 49,121 | 69,374 | 64,009 | 56,101 |
| Operating Income | -441 | -6,570 | -29,674 | -16,263 | -16,170 |
| Interest Expense | 1,198 | 1,283 | 1,310 | 1,400 | 65 |
| Other Income | 3,117 | -2,157 | 4,568 | 4,514 | 4,101 |
| Pre-tax Income | 1,478 | -10,010 | -26,416 | -13,149 | -12,134 |
| Income Tax | 756 | 739 | 459 | 298 | -642 |
| Net Income Continuous | 722 | -10,749 | -26,875 | -13,447 | -11,492 |
| Net Income | $722 | $-10,749 | $-26,875 | $-13,447 | $-11,492 |
| EBITDA(a) | $7,519 | $-3,880 | $-20,157 | $-6,487 | $-11,350 |